Karlis Pauksens

Management of cytomegalovirus infections - Swedish recommendations 2023

Swartling, Lisa; Engman, Mona-Lisa; Eriksen, Jaran; Fischler, Bjoern et al.

Part of Infectious Diseases, p. 907-917, 2024

• DOI for Management of cytomegalovirus infections - Swedish recommendations 2023

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

Hammarstrom, Helena; Krifors, Anders; Athlin, Simon; Friman, Vanda et al.

Part of Clinical Infectious Diseases, 2023

• DOI for Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
• Download full text (pdf) of Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Melin, Jan; Svensson, Maria K.; Albinsson, Bo; Winqvist, Ola et al.

Part of Upsala Journal of Medical Sciences, 2022

• DOI for A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
• Download full text (pdf) of A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Ljunghill Hedberg, Anna; Pauksen, Karlis; Enblad, Per; Larsson, Anders et al.

Part of Human Vaccines & Immunotherapeutics, 2022

• DOI for Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?
• Download full text (pdf) of Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

Hastie, Andrew; Catteau, Grégory; Enemuo, Adaora; Mrkvan, Tomas et al.

Part of Journal of Infectious Diseases, p. 2025-2034, 2021

• DOI for Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination
• Download full text (pdf) of Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

Management of cytomegalovirus infections - Swedish recommendations 2023

Swartling, Lisa; Engman, Mona-Lisa; Eriksen, Jaran; Fischler, Bjoern et al.

Part of Infectious Diseases, p. 907-917, 2024

• DOI for Management of cytomegalovirus infections - Swedish recommendations 2023

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

Hammarstrom, Helena; Krifors, Anders; Athlin, Simon; Friman, Vanda et al.

Part of Clinical Infectious Diseases, 2023

• DOI for Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
• Download full text (pdf) of Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies

A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Melin, Jan; Svensson, Maria K.; Albinsson, Bo; Winqvist, Ola et al.

Part of Upsala Journal of Medical Sciences, 2022

• DOI for A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
• Download full text (pdf) of A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Ljunghill Hedberg, Anna; Pauksen, Karlis; Enblad, Per; Larsson, Anders et al.

Part of Human Vaccines & Immunotherapeutics, 2022

• DOI for Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?
• Download full text (pdf) of Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?

Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

Hastie, Andrew; Catteau, Grégory; Enemuo, Adaora; Mrkvan, Tomas et al.

Part of Journal of Infectious Diseases, p. 2025-2034, 2021

• DOI for Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination
• Download full text (pdf) of Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Welen, Karin; Overby, Anna K.; Ahlm, Clas; Freyhult, Eva et al.

Part of Trials, 2021

• DOI for COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
• Download full text (pdf) of COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections

Venge, Per; Eriksson, Staffan; Pauksen, Karlis

Part of JIM - Journal of Immunological Methods, 2021

• DOI for Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections
• Download full text (pdf) of Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Part of Acta Oncologica, p. 771-778, 2021

• DOI for Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Download full text (pdf) of Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19

Karawajczyk, Malgorzata; Douhan Håkansson, Lena; Lipcsey, Miklós; Hultström, Michael et al.

Part of Therapeutic advances in infectious disease, 2021

• DOI for High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
• Download full text (pdf) of High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19

Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients

Melin, Jan; Svensson, Maria K.; Albinsson, Bo; Winqvist, Ola et al.

Part of BMC Immunology, 2021

• DOI for Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
• Download full text (pdf) of Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients

Calprotectin, a new biomarker for diagnosis of acute respiratory infections

Havelka, Aleksandra; Sejersen, Kristina; Venge, Per; Pauksens, Karlis et al.

Part of Scientific Reports, 2020

• DOI for Calprotectin, a new biomarker for diagnosis of acute respiratory infections
• Download full text (pdf) of Calprotectin, a new biomarker for diagnosis of acute respiratory infections

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

Joona, Therse Bjorkin; Digkas, Evangelos; Wennstig, Anna-Karin; Nystrom, Karin et al.

Part of Breast Cancer Research and Treatment, p. 45-52, 2020

• DOI for Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
• Download full text (pdf) of Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

Oostvogels, Lidia; Heineman, Thomas C.; Johnson, Robert W.; Levin, Myron J. et al.

Part of Human Vaccines & Immunotherapeutics, p. 2865-2872, 2019

• DOI for Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
• Download full text (pdf) of Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

HNL (Human Neutrophil Lipocalin) and a multimarker approach to the distinction between bacterial and viral infections

Venge, Per; Eriksson, Ann-Katrin; Holmgren, Sofia; Douhan Håkansson, Lena et al.

Part of JIM - Journal of Immunological Methods, 2019

• DOI for HNL (Human Neutrophil Lipocalin) and a multimarker approach to the distinction between bacterial and viral infections

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Lopez-Fauqued, Marta; Campora, Laura; Delannois, Frederique; El Idrissi, Mohamed et al.

Part of Vaccine, p. 2482-2493, 2019

• DOI for Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
• Download full text (pdf) of Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Wirksamkeit, Immunogenität und Sicherheit eines adjuvantierten Herpes Zoster-Virus Untereinheiten-Impfstoffkandidaten bei Erwachsenen ab 60 Jahren und älter: Ergebnisse aus den Wirksamkeitsstudien ZOE-50 und ZOE-70

McElhaney, Janet; Lal, Himal; Cunningham, Anthony; Levin, Myron et al.

Part of Der Internist, 2018

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Cunningham, Anthony L.; Heineman, Thomas C.; Lal, Himal; Godeaux, Olivier et al.

Part of Journal of Infectious Diseases, p. 1750-1760, 2018

• DOI for Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
• Download full text (pdf) of Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Kinch, Amelie; Hallböök, Helene; Arvidson, Johan; Sällström, Kalle et al.

Part of Leukemia and Lymphoma, p. 1172-1179, 2018

• DOI for Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Knight, Ann; Pauksen, Karlis; Nordmark, Gunnel; Eva, Kumlien

Part of Rheumatology, p. 855-856, 2017

• DOI for Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery

Ljunghill Hedberg, Anna; Pauksens, Karlis; Enblad, Per; Söderberg, Jessika et al.

Part of Vaccine, p. 909-915, 2017

• DOI for Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery

Epstein-Barr virus-related disease after allogeneic HSCT and use of pre-emptive rituximab: Clinical Features And Outcome

Kinch, Amelie; Hallböök, Helene; Arvidson, Johan; Sällström, K. et al.

Part of Bone Marrow Transplantation, 2017

• DOI for Epstein-Barr virus-related disease after allogeneic HSCT and use of pre-emptive rituximab: Clinical Features And Outcome

Human Neutrophil Lipocalin in Activated Whole Blood Is a Specific and Rapid Diagnostic Biomarker of Bacterial Infections in the Respiratory Tract

Venge, Per; Eriksson, Ann-Katrin; Douhan Håkansson, Lena; Pauksen, Karlis

Part of Clinical and Vaccine Immunology, 2017

• DOI for Human Neutrophil Lipocalin in Activated Whole Blood Is a Specific and Rapid Diagnostic Biomarker of Bacterial Infections in the Respiratory Tract

Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Hertzell, Katarina Brodin; Pauksens, Karlis; Rombo, Lars; Knight, Ann et al.

Part of Vaccine, p. 650-655, 2016

• DOI for Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Chlibek, Roman; Pauksens, Karlis; Rombo, Lars; van Rijckevorsel, Gini et al.

Part of Vaccine, p. 863-868, 2016

• DOI for Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
• Download full text (pdf) of Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study

Hallböök, Helene; Lidström, Anna-Karin; Pauksens, Karlis

Part of INFECTIOUS DISEASES, p. 443-448, 2016

• DOI for Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study

Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Berglund, David; Kinch, Amelie; Edman, Elin; Backlin, Carin et al.

Part of Transplantation, p. 1036-1042, 2015

• DOI for Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults

Ljunghill Hedberg, Anna; Pauksen, Karlis; Ronne-Engström, Elisabeth; Lundberg, Maria et al.

Part of Journal of Infection, p. 577-584, 2015

• DOI for Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults

Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections

Venge, Per; Douhan Håkansson, Lena; Garwicz, Daniel; Peterson, Christer et al.

Part of Clinical and Vaccine Immunology, p. 1025-1032, 2015

• DOI for Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections
• Download full text (pdf) of Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections

Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections

Venge, Per; Douhan, Lena Håkansson; Garwicz, Daniel; Peterson, Christer et al.

Part of JIM - Journal of Immunological Methods, p. 85-90, 2015

• DOI for Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections

Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults.

Ljunghill Hedberg, Anna; Pauksens, Karlis; Ronne-Engström, Elisabeth; Lundberg, Maria et al.

Part of Journal of Infection, p. 577-584, 2015

Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Kinch, Amelie; Cavelier, Lucia; Bengtsson, Mats; Baecklund, Eva et al.

Part of American Journal of Transplantation, p. 2838-2845, 2014

• DOI for Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02(V) in Elderly Adults

Pauksens, Karlis; Nilsson, Anna C.; Caubet, Magalie; Pascal, Thierry G. et al.

Part of Clinical and Vaccine Immunology, p. 651-660, 2014

• DOI for Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02(V) in Elderly Adults

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch, Amelie; Baecklund, Eva; Backlin, Carin; Ekman, Tor et al.

Part of Acta Oncologica, p. 669-679, 2014

• DOI for A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

Chlibek, Roman; Smetana, Jan; Pauksens, Karlis; Rombo, Lars et al.

Part of Vaccine, p. 1745-1753, 2014

• DOI for Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab

Berglund, Åke; Willen, Linda; Grodeberg, Lina; Skattum, Lillemor et al.

Part of Acta Oncologica, p. 1212-1220, 2014

• DOI for The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab

Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccine

Pauksens, Karlis

Part of Infection Ecology & Epidemiology, p. 20766, 2013

• DOI for Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccine

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Rumke, Hans C.; Richardus, Jan Hendrik; Rombo, Lars; Pauksens, Karlis et al.

Part of BMC Infectious Diseases, p. 348, 2013

• DOI for Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
• Download full text (pdf) of Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Part of European Journal of Haematology, p. 413-419, 2013

• DOI for Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Jackson, Lisa A.; Gurtman, Alejandra; Rice, Kathryn; Pauksens, Karlis et al.

Part of Vaccine, p. 3585-3593, 2013

• DOI for Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Clinical and epidemiological findings in patients with pandemic A (H1N1) 2009 influenza in uppsala county, Sweden

Sylvan, Staffan; Christenson, Brith; Pauksens, Karlis; Berglund, Lars

Part of Research Journal of Infectious Diseases, 2013

• DOI for Clinical and epidemiological findings in patients with pandemic A (H1N1) 2009 influenza in uppsala county, Sweden

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Part of Blood, p. 1054, 2012

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

Cordonnier, Catherine; Labopin, Myriam; Chesnel, Virginie; Ribaud, Patricia et al.

Part of Vaccine, p. 2730-2734, 2010

• DOI for Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

Tissue localization and the establishment of a sensitive immunoassay of the newly discovered human phospholipase B-precursor (PLB-P)

Xu, Shengyuan; Cai, Linjun; Zhao, Linshu; Douhan-Håkansson, Lena et al.

Part of JIM - Journal of Immunological Methods, p. 71-77, 2010

• DOI for Tissue localization and the establishment of a sensitive immunoassay of the newly discovered human phospholipase B-precursor (PLB-P)

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation

Cordonnier, Catherine; Labopin, Myriam; Chesnel, Virginie; Ribaud, Patricia et al.

Part of Clinical Infectious Diseases, p. 1392-1401, 2009

• DOI for Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

Christenson, Brith; Pauksen, Karlis; Sylvan, Staffan P. E.

Part of Virology Journal, p. 52, 2008

• DOI for Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia

Pauksens, Karlis; Fjaertoft, Gustav; Douhan-Håkansson, Lena; Venge, Per

Part of Scandinavian Journal of Infectious Diseases, p. 326-37, 2008

• DOI for Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction

Kinch, Amelie; Öberg, Gunnar; Arvidson, Johan; Falk, Kerstin I. et al.

Part of Scandinavian Journal of Infectious Diseases, p. 235-244, 2007

• DOI for Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction

Dynamics of the immune response against extracellular products of group A streptococci during infection

Maripuu, Linda; Eriksson, Anna; Eriksson, Björn; Pauksens, Karlis et al.

Part of Clinical and Vaccine Immunology, p. 44-51, 2007

• DOI for Dynamics of the immune response against extracellular products of group A streptococci during infection

Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies

Mittelholzer, Camilla M.; Brokstad, K. A.; Pauksens, Karlis; Jonsson, R. et al.

Part of Scandinavian Journal of Immunology, p. 257-263, 2006

• DOI for Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies

Concomitant invasive pulmonary aspergillosis and aspergillus sinusitis in a patient with acute leukaemia

Pauksens, Karlis; Oberg, Gunnar

Part of Acta bio-medica : Atenei Parmensis, p. 23-25, 2006

Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications

Fjaertoft, Gustav; Pauksens, Karlis; Håkansson, Lena; Xu, Shengyuan et al.

Part of Scandinavian Journal of Infectious Diseases, p. 882-889, 2005

• DOI for Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications

Low utilisation of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation

Lignell, Anders; Siegbahn, Agneta; Stridsberg, Mats; Pauksen, Karlis et al.

Part of Acta Anaesthesiologica Scandinavica, p. 897-900, 2003

• DOI for Low utilisation of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation

Treatment and prevention of influenza: Swedish recommendations

Uhnoo, Ingrid; Linde, Annika; Pauksens, Karlis; Lindberg, Anders et al.

Part of Scandinavian Journal of Infectious Diseases, p. 3-11, 2003

• DOI for Treatment and prevention of influenza: Swedish recommendations

Skin infection caused by Mycobacterium szulgai after allogenic bone marrow transplantation

Frisk, Per; Boman, Gunnar; Pauksen, Karlis; Petrini, B. et al.

Part of Bone Marrow Transplantation, p. 511-513, 2003

• DOI for Skin infection caused by Mycobacterium szulgai after allogenic bone marrow transplantation

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Ljungman, P.; Ward, K. N.; Crooks, B. N.; Parker, A. et al.

Part of Bone Marrow Transplantation, p. 479-484, 2001

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

Pauksen, Karlis; Linde, Annika; Hammarström, Viera; Sjölin, Jan et al.

Part of Clinical Infectious Diseases, p. 342-348, 2000

• DOI for Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients

Hammarström, Viera; Pauksen, Karlis; Svensson, H.; Lönnqvist, B. et al.

Part of Transplantation, p. 1582-1586, 2000

Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients

Pauksen, Karlis; Sjölin, Jan; Linde, Annika; Andersson, Birger et al.

Part of Scandinavian Journal of Infectious Diseases, p. 43-49, 1999

Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients

Hammarström, Viera; Pauksen, Karlis; Björkstrand, B.; Simonsson, Bengt et al.

Part of Bone Marrow Transplantation, p. 67-71, 1998

Tetanus immunity in patients with hematological malignancies

Hammarström, Viera; Pauksen, Karlis; Svensson, H.; Öberg, G. et al.

Part of Supportive Care in Cancer, p. 469-472, 1998

Th1 and Th2 cytokine response after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination

Pauksen, Karlis; Sjölin, Jan; Linde, Annika; Alm, G. et al.

Part of Bone Marrow Transplantation, p. 317-323, 1997

Antiviral treatment with WIN 54954 reduces mortality in murine Coxsackie virus B3 myocarditis

Fohlman, Jan; Pauksen, Karlis; Hyypiä, T.; Eggertsen, G. et al.

Part of Circulation, p. 2254-2259, 1996

Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients

Ljungman, P.; Öberg, G.; Aschan, J.; Ehrnst, A. et al.

Part of Bone Marrow Transplantation, p. 565-568, 1996

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections

Norrby-Teglund, Anna; Pauksen, Karlis; Norgren, Mari; Holm, Stig

Part of Scandinavian Journal of Infectious Diseases, p. 125-130, 1995

Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections

Xu, S. Y.; Pauksen, Karlis; Venge, Per

Part of Scandinavian Journal of Clinical and Laboratory Investigation, p. 125-131, 1995

The differential release of eosinophil granule proteins: Studies on patients with acute bacterial and viral infections

Karawajczyk, G.; Pauksen, Karlis; Peterson, C.G.; Eklund, E. et al.

Part of Clinical and Experimental Allergy, p. 713-719, 1995